The Recall Desk
LowFDA (Devices)·Z-0501-2016·Announced 2015-12-30

Ameditech Benzodiazepine Drug Test Recall for Reduced Reactivity

Ameditech is recalling EDI BZO Uncut Sheet drug tests because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for documentation or minor issues.

Plain-English summary

Ameditech Inc is recalling 45,584 kits of EDI BZO Uncut Sheet - Cup*, Item No. 160170. The recall is due to reduced reactivity for up to two of the nineteen Benzodiazepine (BZO) compounds listed in the product insert. The specific compounds affected are Clonazepam and Chlordiazepoxide.

The affected products were distributed nationwide. The recall includes lots with the following codes: 141260, 141294, 141909, 141925, 142074, 142243, 142428, 142614, 142712, 142911, 144555, 151925, 152003, 152223, 152498, 152723, 152897, 153311, 153559, 153818, 154184, and 152103.

Consumers and healthcare providers should check their inventory for these specific lot codes and stop using the affected kits. The FDA has classified this as a Class III recall, indicating that the use of the product is not likely to cause adverse health consequences.

The recalled product

Product
EDI BZO Uncut Sheet - Cup*, Item No. 160170
Manufacturer
Ameditech Inc
Affected units
45,584

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 59 recalled by Ameditech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 59 products in this recall →